Effect of metformin therapy on 2-h post-glucose insulin levels in patients of polycystic ovarian syndrome

Journal of Human Reproductive Sciences

Volumn 3, Issue 3, 2010, Pages 139-142

  Saxena, Pikee ^a   Prakash, Anupam ^a   Nigam, Aruna ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

2 h post glucose insulin; hyperinsulinemia; Metformin; PCOS

Indexed keywords

GLUCOSE; INSULIN; LUTEINIZING HORMONE; METFORMIN; TESTOSTERONE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; DIABETES MELLITUS; FEMALE; FEMALE INFERTILITY; HUMAN; INSULIN RESISTANCE; METABOLIC PARAMETERS; OVARY POLYCYSTIC DISEASE; WAIST HIP RATIO;

EID: 78650643655     PISSN: 09741208     EISSN: 19984766     Source Type: Journal    
DOI: 10.4103/0974-1208.74156     Document Type: Article

References (11)

1. Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333:853-61.
2. De Leo V, Musacchio MC, Palermo V, Di Sabatino A, Morgante G, Petraglia F. Polycystic ovary syndrome and metabolic co-morbidities: therapeutic options. Drugs Today 2009;45:763-75.
3. Otta C F, Wior M, Iraci GS, Kaplan R, Torres D, Gaido MI, et al. Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial. Gynecol Endocrinol 2010;26:173-8.
4. Mathur R, Alexander CJ, Yano J, Trivax B, Azziz R. Use of metformin in polycystic ovary syndrome. Am J Obstet Gynecol 2008;199:596-609.
5. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
6. Falsetti L, Gambera A, Andrico S, Sartori E. Acne and hirsutism in polycystic ovary syndrome: clinical, endocrine-metabolic and ultrasonographic differences. Gynecol Endocrinol 2002;16:275-84.
7. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997;20:1183-97.
8. Tong PC, Kong A P, So WY, Yang X, Ho CS, Ma RC, et al. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes. Diabetes Care 2007;30:1206-11.
9. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 1994;43:647-54.
10. Ibanez L, Valls C, Potau N, Marcos M V, de Zegher F. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche. J Clin Endocrinol Metab 2000;85:3526-30. 11.
11. Glueck CJ, Wang P, Fontaine R, Tracy T, Sieve-Smith L. Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome. Metabolism 1999;48:511-9.